Therapeutics controversies in antineutrophilic cytoplasmic antibody-associated vasculitis.

Clin Exp Nephrol · 2025 · PMC12568802 · PMID 40392453

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Due to the heterogeneity of the DAH cohort, they were unable to demonstrate a statistically significant treatment benefit of PLEX in this group, although there was a slight trend to favor PLEX in patients with severe DAH with a hazard ratio of 0.64 (95% CI 0.33–1.24) [ 17 ].

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.